Engineered ACE2-Fc counters murine lethal SARS-CoV-2 infection through direct neutralization and Fc-effector activities

…, G Beaudoin-Bussières, SP Anand, AP Hederman… - Science …, 2022 - science.org
Soluble angiotensin-converting enzyme 2 (ACE2) constitutes an attractive antiviral capable
of targeting a wide range of coronaviruses using ACE2 as their receptor. Using structure-…

Boosting of cross-reactive antibodies to endemic coronaviruses by SARS-CoV-2 infection but not vaccination with stabilized spike

AR Crowley, H Natarajan, AP Hederman, CA Bobak… - Elife, 2022 - elifesciences.org
The ongoing pandemic of SARS-CoV-2 represents the third time in just two decades that a
novel coronavirus (CoV) with significant morbidity and mortality has begun to circulate among …

Leveraging deep learning to improve vaccine design

AP Hederman, ME Ackerman - Trends in Immunology, 2023 - cell.com
Deep learning has led to incredible breakthroughs in areas of research, from self-driving
vehicles to solutions, to formal mathematical proofs. In the biomedical sciences, however, the …

[HTML][HTML] Decoding human-macaque interspecies differences in Fc-effector functions: The structural basis for CD16-dependent effector function in Rhesus macaques

…, N Gohain, PG Kremer, AP Hederman… - Frontiers in …, 2022 - frontiersin.org
Fc mediated effector functions of antibodies play important roles in immunotherapies and
vaccine efficacy but assessing those functions in animal models can be challenging due to …

[HTML][HTML] SARS-CoV-2 vaccination elicits broad and potent antibody effector functions to variants of concern in vulnerable populations

AP Hederman, H Natarajan, L Heyndrickx… - Nature …, 2023 - nature.com
SARS-CoV-2 variants have continuously emerged in the face of effective vaccines. Reduced
neutralization against variants raises questions as to whether other antibody functions are …

Characterization of SARS-CoV-2 Convalescent Patients' Serological Repertoire Reveals High Prevalence of Iso-RBD Antibodies

NC Curtis, S Shin, AP Hederman, RI Connor… - bioRxiv, 2023 - biorxiv.org
While our understanding of SARS-CoV-2 pathogenesis and antibody responses following
infection and vaccination has improved tremendously since the outbreak in 2019, the …

[HTML][HTML] SARS-CoV-2 mRNA vaccination elicits broad and potent Fc effector functions to VOCs in vulnerable populations

AP Hederman, H Natarajan, JA Wiener, PF Wright… - medRxiv, 2022 - ncbi.nlm.nih.gov
SARS-CoV-2 variants have continuously emerged even as highly effective vaccines have
been widely deployed. Reduced neutralization observed against variants of concern (VOC) …

[HTML][HTML] Incorporating the cluster A and V1V2 targets into a minimal structural unit of the HIV-1 envelope to elicit a cross-clade response with potent Fc-effector …

…, WD Tolbert, S Gottumukkala, AP Hederman… - Vaccines, 2021 - mdpi.com
The generation of a potent vaccine for the prevention and/or control of HIV-1 has been
unsuccessful to date, despite decades of research. Existing evidence from both infected …

Discrimination of Primary and Chronic CMV Infection based on Humoral Immune Profiles in Pregnancy

AP Hederman, CJ Remmel, S Sharma, H Natarajan… - medRxiv, 2024 - medrxiv.org
Most humans have been infected by Cytomegalovirus (CMV) by the time they reach forty years
of age. Whereas most of these CMV infections are well controlled by the immune system, …

SARS-CoV-2 mRNA vaccination elicits broad and potent Fc effector functions to VOCs in vulnerable populations (preprint)

AP Hederman, H Natarajan, JA Wiener, PF Wright… - 2022 - pesquisa.bvsalud.org
SARS-CoV-2 variants have continuously emerged even as highly effective vaccines have
been widely deployed. Reduced neutralization observed against variants of concern (VOC) …